The Technical Analyst
MedAvail Holdings, Inc. [MDVL]
Exchange: NASDAQ Sector: Healthcare Industry: Pharmaceutical Retailers
MedAvail Holdings, Inc. Price, Forecast, Insider, Ratings, Fundamentals & Signals
-43.22% $1.800
America/New_York / 12 feb 2024 @ 16:00
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 2.91 mill |
| EPS: | -35.56 |
| P/E: | -0.0506 |
| Earnings Date: | Apr 10, 2024 |
| SharesOutstanding: | 1.614 mill |
| Avg Daily Volume: | 0.129 mill |
| RATING 2024-02-12 |
|---|
| B- |
| Neutral |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Neutral | |
| Return On Equity: | Strong Sell | |
| Return On Asset: | Sell | |
| DE: | Neutral | |
| P/E: | Sell | |
| Price To Book: | Buy |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 1/22 | 2/22 | 3/22 | 4/22 | 1/23 | 2/23 | |
| Revenue | ||||||
| Gr.Profit | ||||||
| Ebit | ||||||
| Asset | ||||||
| Debt |
| PE RATIO: COMPANY / SECTOR |
|---|
| 0.00x |
| Company: PE -0.0506 | sector: PE -3.05 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| -0.01x |
| Company: PE -0.0506 | industry: PE 7.30 |
| DISCOUNTED CASH FLOW VALUE |
|---|
| N/A |
| N/A |
| Expected Trading Range (DAY) |
|---|
|
$ 0.663 - 2.16 ( +/- 52.98%) |
| ATR Model: 14 days |
Insider Trading
| Date | Person | Action | Amount | type |
|---|---|---|---|---|
| 2024-02-02 | Faulkner Robert C. | Buy | 0 | |
| 2023-09-01 | Seabaugh Ramona | Buy | 680 | Common Stock |
| 2023-09-28 | Seabaugh Ramona | Sell | 303 | Common Stock |
| 2023-09-01 | Seabaugh Ramona | Sell | 680 | Restricted Stock Units |
| 2023-08-18 | Doerr Mark Edward | Buy | 125 000 | Stock Options (Right to Buy) |
| INSIDER POWER |
|---|
| 99.32 |
| Last 90 transactions |
| Buy: 181 157 067 | Sell: 10 195 984 |
Forecast:
01:40 - $1.976
Live Trading Signals (every 1 min)
SCORE
10.00
Buy
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 | |
| MACD |
| Volume Signals | |
|---|---|
| Price | $1.800 (-43.22% ) |
| Volume | 0.236 mill |
| Avg. Vol. | 0.129 mill |
| % of Avg. Vol | 183.39 % |
| Signal 1: | |
| Signal 2: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For MDVL
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % |
|---|
MDVL
MedAvail Holdings, Inc., a technology-enabled retail pharmacy technology and services company, develops and commercializes self-service pharmacy, mobile application, kiosk, and drive-thru solutions in the United States and Canada. It operates in two segments, Retail Pharmacy Services and Pharmacy Technology. The company's MedCenter enables on-site pharmacy in medical clinics, retail store locations, employer sites with and without onsite clinics, and other location where onsite prescription dispensing is desired, as well as establishes an audio-visual connection to a live pharmacist enabling prescription drug dispensing to occur directly to a patient with real-time supervision by a pharmacist. It also owns and operates SpotRx, a retail pharmacy platform. As of December 31, 2021, the company had 81 MedCenter kiosks. MedAvail Holdings, Inc. is headquartered in Mississauga, Canada.
Last 10 Buy Signals
Latest Press Releases
2023-11-28 07:00:00 - Press Release
Medavail Announces Agreement With New Orleans-based St. Thomas Community Health Centers For Deployment Of Two M4 Medcenters
Expands medavail's presence among federally qualified health centers (fqhcs) expands medavail's presence among federally qualified health centers (fqhcs)
2023-11-17 16:05:00 - Press Release
Medavail Receives Nasdaq Notification Of Non-compliance Related to Delayed Quarterly Report On Form 10-q
Phoenix, nov. 17, 2023 (globe newswire) -- medavail holdings, inc. (nasdaq: mdvl) (“medavail” or the “company”), an innovative pharmacy technology company, announced today that on november 16, 2023, the company received a delinquency notification letter from the listing qualifications department of the nasdaq stock market indicating that the company was not in compliance with nasdaq listing rule 5250(c)(1) as a result of its failure to have timely filed its quarterly report on form 10-q for the quarter ended september 30, 2023 with the securities and exchange commission.
2023-11-17 08:00:00 - Press Release
Medavail Announces Agreement With Asp Cares For Deployment Of Ten M4 Medcenters
Initial three deployments to be completed in early 2024 at asp cares pharmacy in las vegas agreement repsents expansion of successful relationship with dallas-based oak lawn pharmacy phoenix, nov. 17, 2023 (globe newswire) -- medavail holdings, inc. (nasdaq: mdvl) (“medavail”), an innovative pharmacy technology company, announced today that it has entered into an agreement with pharmacy fund 1 for the deployment of ten m4 medcenter kiosks, which will be serviced by asp cares pharmacy. pharmacy fund 1 also operates oaklawn pharmacy, which is a current medavail partner in dallas, texas.
2023-08-14 16:49:00 - Press Release
Medavail Reports Second Quarter 2023 Financial Results
Phoenix, aug. 14, 2023 (globe newswire) -- medavail holdings, inc. (nasdaq: mdvl) (“medavail”), an innovative pharmacy technology company, today reported financial results for the second quarter ended june 30, 2023.
2023-08-04 08:00:00 - Press Release
Medavail Announces Agreement With Dallas-based Oak Lawn Pharmacy For Deployment Of Ten M4 Medcenters
Oak lawn pharmacy to deploy two m4 kiosks in 2023, with the remaining units to be deployed within 24 months of contract execution
Latest News
2023-05-18 22:46:08 - Seeking Alpha
MedAvail Holdings, Inc. (MDVL) Q1 2023 Earnings Call Transcript
MedAvail Holdings, Inc. (NASDAQ:MDVL ) Q1 2023 Results Conference Call May 18, 2023 4:30 PM ET Company Participants Steve Halper - Managing Director at LifeSci Advisors Mark Doerr - Chief Executive Officer Ramona Seabaugh - Chief Financial Officer Conference Call Participants Lucas Romanski - TD Cowen Operator Hello, everyone. And thank you for joining MedAvail's 2023 First Quarter Conference Call.
2023-05-18 07:00:00 - GlobeNewsWire
MedAvail to Report First Quarter 2023 Financial Results on May 18
Management to host investor conference call and webcast at 4:30pm EDT today Management to host investor conference call and webcast at 4:30pm EDT today
2023-05-15 12:21:00 - GlobeNewsWire
MedAvail to Report First Quarter 2023 Financial Results on May 15
Management to host investor conference call and webcast at 4:30 pm EDT today Management to host investor conference call and webcast at 4:30 pm EDT today
2023-04-14 15:24:02 - Seeking Alpha
MedAvail Holdings, Inc. (MDVL) Q4 2022 Earnings Call Transcript
MedAvail Holdings, Inc. (NASDAQ:MDVL ) Q4 2022 Earnings Conference Call April 13, 2023 4:30 PM ET Company Participants Steven Halper - MD, LifeSci Advisors, IR Mark Doerr - CEO Ramona Seabaugh - CFO Conference Call Participants Charles Rhyee - Cowen & Co. Operator Hello, everyone, and thank you for joining the MedAvail's 2022 Fourth Quarter and Full Year Conference Call. My name is Doug.
2023-04-12 16:05:00 - GlobeNewsWire
MedAvail to Report Fourth Quarter and Full Year 2022 Financial Results on April 13
Management to host investor conference call and webcast at 4:30pm EDT on that day Management to host investor conference call and webcast at 4:30pm EDT on that day
2023-03-16 16:05:00 - GlobeNewsWire
MedAvail to Report Fourth Quarter and Full Year 2022 Financial Results on March 30
Management to host investor conference call and webcast at 4:30pm ET on that day Management to host investor conference call and webcast at 4:30pm ET on that day
2022-12-12 08:36:58 - Benzinga
Most Oversold Stocks In Consumer Staples Sector: Herbalife, United Natural Foods And More - Herbalife Nutrition (NYSE:HLF), AppHarvest (NASDAQ:APPH)
The most oversold stocks in the consumer staples sector presents an opportunity to buy into undervalued companies. Here's the latest list of major oversold players in this sector.
2022-11-13 19:40:25 - Seeking Alpha
MedAvail Holdings, Inc. (MDVL) Q3 2022 Earnings Call Transcript
MedAvail Holdings, Inc. (NASDAQ:MDVL ) Q3 2022 Earnings Conference Call November 10, 2022 4:30 PM ET Company Participants Ji-Yon Yi - IR Mark Doerr - CEO Ramona Seabaugh - CFO Conference Call Participants Brooks O'Neil - Lake Street Capital Markets Operator Hello, everyone, and thank you for joining the MedAvail's 2022 Third Quarter Earnings Conference Call. My name is Daren, I'll be your operator for today.
2022-10-27 16:05:00 - Business Wire
MedAvail To Report 2022 Third Quarter Financial Results on November 10, 2022
2022-08-30 16:05:00 - Business Wire
MedAvail to Present at the H.C. Wainwright 24th Annual Global Investment Conference
MISSISSAUGA, Ontario & PHOENIX, Ariz.--(BUSINESS WIRE)--MedAvail Holdings, Inc. (Nasdaq: MDVL) (“MedAvail”) a technology-enabled retail pharmacy company, today announced that the company will be participating in the upcoming hybrid H.C. Wainwright 24th Annual Global Investment Conference in New York. MedAvail's management is scheduled to present on Tuesday, September 13, 2022, at 2:30 p.m. Eastern Time. Interested parties may access a live and archived webcast of the presentation on the “Invest